Stay updated on Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdate adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.SummaryDifference2%
- Check20 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and a 'Back to Top' control was removed; overall, these are minor changes with no impact on core content.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations, as well as new drug information related to Fenfluramine and Dravet syndrome. However, several previous entries related to drug information and locations have been removed.SummaryDifference4%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.